Gilead Backs Chancery In Appeal Of $50M Merger Bonus Suit
Pharmaceutical firm Gilead Sciences Inc. filed an answering brief Monday to the Delaware Supreme Court defending the decision of the state's Chancery Court after a trial over a $50 million merger...To view the full article, register now.
Already a subscriber? Click here to view full article